Blinatumomab<\/b>, sold under the brand name\u00a0Blincyto<\/b>, is a\u00a0biopharmaceutical\u00a0medication used for the treatment of\u00a0Philadelphia chromosome-negative relapsed or refractory\u00a0acute lymphoblastic leukemia.<\/sup>\u00a0It belongs to a class of constructed\u00a0monoclonal antibodies,\u00a0bi-specific T-cell engagers\u00a0(BiTEs), that exert action selectively and direct the human immune system to act against tumor cells.<\/p>\n Blinatumomab was approved for medical use in the United States in December 2014, <\/sup>in Australia in November 2015,<\/sup> in Canada in March 2016,\u00a0<\/sup>and in the European Union in November 2023.<\/sup><\/p>\n BLINCYTO (blinatumomab) for Injection is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.<\/p>\n If BLINCYTO (blinatumomab) for Injection are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN.<\/strong> For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. Like 1. How to get access in in India. 2. Medicine Price. 3. Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia. 4. Ensuring 100% transparency.\u00a0<\/strong><\/p>\n BLINCYTO (blinatumomab) for Injection can be made available to patients, doctors, and hospitals in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.<\/p>\n To receive comprehensive support, please call us at 9811747774<\/a>, 9891296838<\/a> or WhatsApp at 9811747774<\/a>, 9891296838 <\/a>or email us at info@indianpharmanetwork.co.in\u00a0<\/a> for BLINCYTO (blinatumomab) for Injection in India.<\/strong><\/p>\n NEWS \/ UPDATES<\/strong><\/p>\n Note:<\/strong><\/em> Blincyto is a prescription only medicine, which is used in treating patients with B-cell precursor acute lymphoblastic leukemia in first or second complete remission with minimal residual disease greater than or equal 0.1% and relapsed or refractory B-cell precursor ALL (Acute Lymphoblastic Leukemia).<\/p>\nBLINCYTO (blinatumomab) for injection, for intravenous use Initial U.S. Approval: 2014<\/h4>\n
Is BLINCYTO available in India?<\/h4>\n
\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient. Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India<\/a>. With over two decades of industry experience, IPN offers extensive coverage across India.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"Brand Name: BLINCYTO Generic Name: blinatumomab. It is used to treat Acute Lymphoblastic Leukemia.<\/h2>\n